| Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections—United States AP Kourtis MMWR. Morbidity and mortality weekly report 68, 2019 | 635* | 2019 |
| Vital signs: improving antibiotic use among hospitalized patients MD Scott Fridkin, J Baggs, SM MD, PM MD, PDMA Rubin, MHS MD, ... Morbidity and mortality weekly report 69 (9), 194-200, 2014 | 564 | 2014 |
| Multidrug-resistant bacterial infections in US hospitalized patients, 2012–2017 JA Jernigan, KM Hatfield, H Wolford, RE Nelson, B Olubajo, SC Reddy, ... New England Journal of Medicine 382 (14), 1309-1319, 2020 | 420 | 2020 |
| Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures NP Klein, B Fireman, WK Yih, E Lewis, M Kulldorff, P Ray, R Baxter, ... Pediatrics 126 (1), e1-e8, 2010 | 377 | 2010 |
| Underlying medical conditions associated with severe COVID-19 illness among children L Kompaniyets, NT Agathis, JM Nelson, LE Preston, JY Ko, B Belay, ... JAMA network open 4 (6), e2111182-e2111182, 2021 | 362 | 2021 |
| Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink J Gee, A Naleway, I Shui, J Baggs, R Yin, R Li, M Kulldorff, E Lewis, ... Vaccine 29 (46), 8279-8284, 2011 | 314 | 2011 |
| The Vaccine Safety Datalink: a model for monitoring immunization safety J Baggs, J Gee, E Lewis, G Fowler, P Benson, T Lieu, A Naleway, ... Pediatrics 127 (Supplement_1), S45-S53, 2011 | 299 | 2011 |
| Peer reviewed: underlying medical conditions and severe illness among 540,667 adults hospitalized with COVID-19, March 2020–March 2021 L Kompaniyets, AF Pennington, AB Goodman, HG Rosenblum, B Belay, ... Preventing chronic disease 18, 2021 | 288 | 2021 |
| Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012 J Baggs, SK Fridkin, LA Pollack, A Srinivasan, JA Jernigan JAMA internal medicine 176 (11), 1639-1648, 2016 | 272 | 2016 |
| Risk of intussusception after monovalent rotavirus vaccination ES Weintraub, J Baggs, J Duffy, C Vellozzi, EA Belongia, S Irving, ... New England Journal of Medicine 370 (6), 513-519, 2014 | 243 | 2014 |
| National estimates of healthcare costs associated with multidrug-resistant bacterial infections among hospitalized patients in the United States RE Nelson, KM Hatfield, H Wolford, MH Samore, RD Scott, SC Reddy, ... Clinical Infectious Diseases 72 (Supplement_1), S17-S26, 2021 | 178 | 2021 |
| COVID-19 vaccine safety in adolescents aged 12–17 years—United States, December 14, 2020–July 16, 2021 AM Hause MMWR. Morbidity and mortality weekly report 70, 2021 | 178 | 2021 |
| Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants IM Shui, J Baggs, M Patel, UD Parashar, M Rett, EA Belongia, ... Jama 307 (6), 598-604, 2012 | 171 | 2012 |
| COVID-19 vaccine safety in children aged 5–11 years—United States, November 3–December 19, 2021 AM Hause MMWR. Morbidity and mortality weekly report 70, 2021 | 168 | 2021 |
| Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine EA Belongia, SA Irving, IM Shui, M Kulldorff, E Lewis, R Yin, TA Lieu, ... The Pediatric infectious disease journal 29 (1), 1, 2010 | 165* | 2010 |
| Risk of subsequent sepsis within 90 days after a hospital stay by type of antibiotic exposure J Baggs, JA Jernigan, AL Halpin, L Epstein, KM Hatfield, LC McDonald Clinical infectious diseases 66 (7), 1004-1012, 2018 | 160 | 2018 |
| Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007 P Haber, M Patel, HS Izurieta, J Baggs, P Gargiullo, E Weintraub, ... Pediatrics 121 (6), 1206-1212, 2008 | 147 | 2008 |
| Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project WK Yih, M Kulldorff, BH Fireman, IM Shui, EM Lewis, NP Klein, J Baggs, ... Pediatrics 127 (Supplement_1), S54-S64, 2011 | 146 | 2011 |
| Impact of HIV type 1 subtype variation on viral RNA quantitation B Parekh, S Phillips, TC Granade, J Baggs, DJ Hu, R Respess AIDS research and human retroviruses 15 (2), 133-142, 1999 | 139 | 1999 |
| H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project GM Lee, SK Greene, ES Weintraub, J Baggs, M Kulldorff, BH Fireman, ... American journal of preventive medicine 41 (2), 121-128, 2011 | 137 | 2011 |
Eric S. WeintraubVerified email at cdc.gov
